Longevity
Research Brief
How the GlyNAC Dual-Precursor Bypasses the Rate-Limiting Step in Glutathione Synthesis
5 sources · 2d ago
Deep Dive
The Science of Senolytics: How 'Senolytic Cocktails' Target Senescent Cells to Extend Healthspan
11 sources · 4d ago
Explainer
The Science of Epigenetic Clocks: Comparing the Accuracy and Utility of Horvath, Hannum, and DunedinPACE
7 sources · 7d ago
More in Longevity
Personalized OncologyClinical Trial Results
Moderna and Merck’s Personalized mRNA Cancer Vaccine Hits Phase 3 Goals in Landmark Melanoma Trial
Clinical Researchers 40%Industry & Investors 35%Patient Advocates 25%
6 sources · 9d ago
Research BriefLongevity Genetics
Landmark Study Finds Exceptional Longevity Is Inherited: Centenarians' Children Have 42% Lower Mortality Risk
Genetic Determinism Researchers 40%Lifestyle & Environmental Analysts 35%Pharmacological Prevention Advocates 25%
4 sources · 11d ago
Research BriefBiological Age
Simple 10-Second Balance Test Predicts 84% Higher Mortality Risk, Emerging as Key Longevity Marker
Clinical Researchers 40%Rehabilitation Specialists 35%Public Health Analysts 25%
4 sources · 14d ago
Alzheimer's DiseaseClinical Trial
New Tau-Targeting Drug Halves Cognitive Decline in Alzheimer's Phase 2 Trial
Clinical Researchers 40%Alzheimer's Advocacy Groups 30%Cautious Analysts 30%
7 sources · 16d ago
Metabolic HealthClinical Trial Results
First-in-Class GLP-1 Antagonist Slashes Hypoglycemia Risk by 55% in Phase 3 Trial for Post-Bariatric Surgery Complication
Endocrinologists & Surgeons 41%PBH Patients 41%Metabolic Researchers 18%
6 sources · 19d ago
Cellular ReprogrammingEvidence Pack
First Human Trial of Cellular Reprogramming Therapy Begins, Targeting Vision Loss
Longevity Researchers 40%Clinical Safety Monitors 35%Ophthalmology Advocates 25%
8 sources · 21d ago
Aging BiologyTrial Watch
Landmark $38M Trial Tests Rapamycin and GLP-1 Drugs to Extend Human Healthspan
Geroscience Researchers 40%Clinical Skeptics 30%Public Health Advocates 30%
7 sources · 24d ago
ExplainerRegenerative Medicine
How iPSC Therapies Are Reversing Heart Failure and Parkinson's Disease
Regenerative Medicine Researchers 45%Industry Analysts 30%Clinical Skeptics 25%
7 sources · 29d ago